Press Releases
Hogan Lovells advises CI Financial on acquisition of Brightworth
16 March 2021
Michael Szlamkowicz
PartnerNew York
Email [email protected]hoganlovells.com
Phone +1 212 918 3222
Fax +1 212 918 3100
Practice groupCorporate & Finance
Michael Szlamkowicz takes a business-oriented approach to his work, helping his clients anticipate and solve a wide range of commercial and legal challenges.
Michael focuses his practice on complex corporate and transactional matters and primarily represents private equity and pension fund sponsors and their portfolio companies, especially in connection with leveraged acquisitions, divestitures, joint ventures, minority investments, financings, restructurings, and general corporate matters.
He also has comprehensive experience with both international and domestic transactions, and frequently counsels on a variety of securities law, corporate governance, and strategic matters. His industry experience includes life sciences, energy, media, fashion and branding, entertainment, telecommunications, information technology, retail, automotive, chemical, and financial services.
Michael studied at McGill University and the Université de Montréal.
Awards and recognitions
2020
M&A/Corporate and Commercial: M&A Large Deals ($1bn+)
Legal 500 US
2018
Healthcare: Life Sciences
Legal 500 US
Education and admissions
Education
Bachelor of Commerce (Finance, Marketing), McGill University
Bachelor of Laws, University of Montreal
J.D., University of Montreal
Bar admissions and qualifications
New York
Quebec
Representative experience
21st Century Fox in its joint venture with Apollo to create a leading global multi-platform content provider, bringing together Endemol and Shine Group.
Actis on its sale of Anthelio Healthcare Solutions to Atos.
Alcon in the acquisition of Transcend Medical, Inc., developer of technologies for the treatment of glaucoma.
Ford on its acquisition of SAIPS, an Israel-based machine learning company.
Google in its acquisition of Lift Labs.
Next Issue Media in connection with a US$50m investment by KKR.
Novartis in its acquisition of Encore Vision, focused on the development of a novel treatment in presbyopia.
Novartis in its US$665m acquisition of Selexys Pharmaceuticals, a developer of therapeutics to treat pain associated with blood/inflammatory disorders like sickle cell disease.
One Rock Capital on its acquisition of Chevron's Hawaii assets.
One Rock Capital on its acquisition of FXI, a leading foam producer.
Pamplona Capital in its acquisition of BBB Industries.
Pamplona Capital in its acquisition of Charter Nex Holdings.
Pfizer on its immuno-oncology research collaboration with Western Oncolytics to investigate novel oncolytic virus technology.
Valeant on the sale of Dendreon Pharmaceuticals, Inc. to the Sanpower Group Co., Ltd for US$820m.
*Matter handled prior to joining Hogan Lovells.
Latest thinking and events
Press Releases
Hogan Lovells advises Novartis on Vedere Bio acquisition
10 November 2020
Published Works
5 points to consider before entering a distressed M&A deal Mergers & Acquisitions Magazine
17 July 2020
Press Releases
Hogan Lovells advises pipeline integrity specialist NDT Global Limited on the sale of NDT Global Group to Canadian Eddyfi NDT Inc.
07 February 2020
Press Releases
Hogan Lovells advises on acquisition of Connecticut Service Plazas
22 October 2019
Hogan Lovells Events
Hogan Lovells Sovereign Investor Conference
22 October 2019
